医药-话题@MedSci

#医药#

1668篇内容 | 3273人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1410205, encodeId=104f141020589, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=综述：中医药对抗溃疡性结肠炎机制, objectType=article, longId=300859, objectId=1e873008594a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e873008594a, replyNumber=0, likeNumber=120, createdTime=2022-03-17, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e873008594a, moduleTitle=综述：中医药对抗溃疡性结肠炎机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e873008594a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410204, encodeId=257414102042c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=默克与思路迪医药达成临床研究合作，共同探索创新“靶向+肿瘤免疫”联合疗法治疗转移性结直肠癌, objectType=article, longId=300740, objectId=1daa300e408c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1daa300e408c, replyNumber=0, likeNumber=104, createdTime=2022-03-16, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1daa300e408c, moduleTitle=默克与思路迪医药达成临床研究合作，共同探索创新“靶向+肿瘤免疫”联合疗法治疗转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1daa300e408c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410203, encodeId=98701410203f6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=阿南达医药科技与纽约大学格罗斯曼医学院宣布神经根性疼痛患者阿片类节量治疗临床试验入组首例患者, objectType=article, longId=300444, objectId=42bb30044406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42bb30044406, replyNumber=0, likeNumber=86, createdTime=2022-03-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42bb30044406, moduleTitle=阿南达医药科技与纽约大学格罗斯曼医学院宣布神经根性疼痛患者阿片类节量治疗临床试验入组首例患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42bb30044406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410202, encodeId=296814102020a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2022年3月10日简报：本土感染连续3天超500例，无头疫情增多；香港新增25991例确诊病例，疫情好转；中国医药确认拿下2022年度辉瑞新冠特效药在大陆的销售权, objectType=article, longId=300415, objectId=3d5e3004157b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d5e3004157b, replyNumber=0, likeNumber=93, createdTime=2022-03-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d5e3004157b, moduleTitle=2022年3月10日简报：本土感染连续3天超500例，无头疫情增多；香港新增25991例确诊病例，疫情好转；中国医药确认拿下2022年度辉瑞新冠特效药在大陆的销售权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d5e3004157b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410201, encodeId=9d20141020156, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=广州中医药大学登顶BMJ：针灸在8种疾病中有显著效果，却在临床和政策中缺席, objectType=article, longId=300090, objectId=491f300090e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=491f300090e4, replyNumber=0, likeNumber=35, createdTime=2022-03-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=491f300090e4, moduleTitle=广州中医药大学登顶BMJ：针灸在8种疾病中有显著效果，却在临床和政策中缺席, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=491f300090e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410200, encodeId=ab7c14102007d, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中医药治疗心血管疾病疗效评价, objectType=article, longId=300048, objectId=271730004894, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=271730004894, replyNumber=0, likeNumber=103, createdTime=2022-03-06, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=271730004894, moduleTitle=中医药治疗心血管疾病疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=271730004894)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410199, encodeId=a2a314101998b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=2022年两会：哪些提案与医疗和医药有关？长护险、互联网医院、罕见病、数据银行, objectType=article, longId=300002, objectId=abc830000299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abc830000299, replyNumber=0, likeNumber=75, createdTime=2022-03-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abc830000299, moduleTitle=2022年两会：哪些提案与医疗和医药有关？长护险、互联网医院、罕见病、数据银行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abc830000299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410198, encodeId=9c311410198fe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=国际骨髓瘤关爱月 | 德琪医药携手各方，助力骨髓瘤规范诊疗, objectType=article, longId=299553, objectId=e7182995536f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7182995536f, replyNumber=0, likeNumber=84, createdTime=2022-02-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7182995536f, moduleTitle=国际骨髓瘤关爱月 | 德琪医药携手各方，助力骨髓瘤规范诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7182995536f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410197, encodeId=6e7e141019e96, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=连花清瘟胶囊作为中医药抗疫“三药三方”的代表产品驰援香港抗疫, objectType=article, longId=299541, objectId=4bd4299541cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bd4299541cf, replyNumber=0, likeNumber=79, createdTime=2022-02-25, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bd4299541cf, moduleTitle=连花清瘟胶囊作为中医药抗疫“三药三方”的代表产品驰援香港抗疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bd4299541cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410196, encodeId=98b9141019671, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=华领医药宣布与药明康德子公司签订合作协议, objectType=article, longId=299337, objectId=455429933ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=455429933ed1, replyNumber=0, likeNumber=73, createdTime=2022-02-23, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=455429933ed1, moduleTitle=华领医药宣布与药明康德子公司签订合作协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=455429933ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410191, encodeId=5cf5141019160, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=追缴医保基金4.6亿！去年共关停299家医药机构, objectType=article, longId=295907, objectId=1d4929590ea3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d4929590ea3, replyNumber=0, likeNumber=98, createdTime=2022-02-18, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d4929590ea3, moduleTitle=追缴医保基金4.6亿！去年共关停299家医药机构, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d4929590ea3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410194, encodeId=35a61410194ac, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=中国民族医药治疗成人失眠的专家共识, objectType=article, longId=295331, objectId=8f5b2953313d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f5b2953313d, replyNumber=0, likeNumber=35, createdTime=2022-02-11, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f5b2953313d, moduleTitle=中国民族医药治疗成人失眠的专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f5b2953313d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410195, encodeId=fd261410195ae, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=系统评价和荟萃分析：中医药联合化疗治疗乳腺癌, objectType=article, longId=295318, objectId=de0229531841, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de0229531841, replyNumber=0, likeNumber=79, createdTime=2022-02-10, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de0229531841, moduleTitle=系统评价和荟萃分析：中医药联合化疗治疗乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de0229531841)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410193, encodeId=1b26141019301, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO", objectType=article, longId=294185, objectId=e70429418531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e70429418531, replyNumber=0, likeNumber=63, createdTime=2022-01-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e70429418531, moduleTitle=精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO", moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e70429418531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410192, encodeId=3be714101927c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权, objectType=article, longId=294113, objectId=9c492941132f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c492941132f, replyNumber=0, likeNumber=87, createdTime=2022-01-18, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c492941132f, moduleTitle=NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c492941132f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410190, encodeId=5fa21410190b0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=同源康医药完成3.3亿元C轮融资，厚纪资本领投，凯乘资本担任独家财务顾问, objectType=article, longId=293567, objectId=4d4029356eed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d4029356eed, replyNumber=0, likeNumber=76, createdTime=2022-01-09, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d4029356eed, moduleTitle=同源康医药完成3.3亿元C轮融资，厚纪资本领投，凯乘资本担任独家财务顾问, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d4029356eed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410189, encodeId=b49214101895b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=阿南达医药科技宣布FDA批准了针对阿片类用药障碍（OUD）的新药临床试验申请, objectType=article, longId=293497, objectId=fed229349e39, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fed229349e39, replyNumber=0, likeNumber=104, createdTime=2022-01-07, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fed229349e39, moduleTitle=阿南达医药科技宣布FDA批准了针对阿片类用药障碍（OUD）的新药临床试验申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fed229349e39)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410188, encodeId=61da1410188d4, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=四环医药（0460.HK）：轩竹生物完成超6亿元B轮融资，阳光人寿领投，凯乘资本担任独家财务顾问, objectType=article, longId=293386, objectId=5475293386af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5475293386af, replyNumber=0, likeNumber=63, createdTime=2022-01-05, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5475293386af, moduleTitle=四环医药（0460.HK）：轩竹生物完成超6亿元B轮融资，阳光人寿领投，凯乘资本担任独家财务顾问, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5475293386af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410187, encodeId=ae0a141018ec0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=凌腾医药宣布，卡妥索双抗用于介苗治疗失败的非肌层浸润性膀胱癌的1期临床试验已完成首例患者给药, objectType=article, longId=221841, objectId=a33c221841fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a33c221841fa, replyNumber=0, likeNumber=80, createdTime=2021-12-12, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a33c221841fa, moduleTitle=凌腾医药宣布，卡妥索双抗用于介苗治疗失败的非肌层浸润性膀胱癌的1期临床试验已完成首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a33c221841fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1410186, encodeId=61ab14101863c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, objectTitle=丁香园生态合作伙伴大会在上海举行，聚焦医药数字化营销浪潮, objectType=article, longId=220596, objectId=97752205966b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97752205966b, replyNumber=0, likeNumber=37, createdTime=2021-11-20, rootId=0, userName=cathymary, userId=36f62754598, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97752205966b, moduleTitle=丁香园生态合作伙伴大会在上海举行，聚焦医药数字化营销浪潮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97752205966b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

医药

2020-05-29

cathymary (审核中...)

前往app查看评论内容

#医药#

综述：中医药对抗溃疡性结肠炎机制

2022-03-17

cathymary (审核中...)

前往app查看评论内容

#医药#

默克与思路迪医药达成临床研究合作，共同探索创新“靶向+肿瘤免疫”联合疗法治疗转移性结直肠癌

2022-03-16

cathymary (审核中...)

前往app查看评论内容

#医药#

阿南达医药科技与纽约大学格罗斯曼医学院宣布神经根性疼痛患者阿片类节量治疗临床试验入组首例患者

2022-03-12

cathymary (审核中...)

前往app查看评论内容

#医药#

2022年3月10日简报：本土感染连续3天超500例，无头疫情增多；香港新增25991例确诊病例，疫情好转；中国医药确认拿下2022年度辉瑞新冠特效药在大陆的销售权

2022-03-11

cathymary (审核中...)

前往app查看评论内容

#医药#

广州中医药大学登顶BMJ：针灸在8种疾病中有显著效果，却在临床和政策中缺席

2022-03-06

cathymary (审核中...)

前往app查看评论内容

#医药#

中医药治疗心血管疾病疗效评价

2022-03-06

cathymary (审核中...)

前往app查看评论内容

#医药#

2022年两会：哪些提案与医疗和医药有关？长护险、互联网医院、罕见病、数据银行

2022-03-05

cathymary (审核中...)

前往app查看评论内容

#医药#

国际骨髓瘤关爱月 | 德琪医药携手各方，助力骨髓瘤规范诊疗

2022-02-25

cathymary (审核中...)

前往app查看评论内容

#医药#

连花清瘟胶囊作为中医药抗疫“三药三方”的代表产品驰援香港抗疫

2022-02-25

cathymary (审核中...)

前往app查看评论内容

#医药#

华领医药宣布与药明康德子公司签订合作协议

2022-02-23

cathymary (审核中...)

前往app查看评论内容

#医药#

追缴医保基金4.6亿！去年共关停299家医药机构

2022-02-18

cathymary (审核中...)

前往app查看评论内容

#医药#

中国民族医药治疗成人失眠的专家共识

2022-02-11

cathymary (审核中...)

前往app查看评论内容

#医药#

系统评价和荟萃分析：中医药联合化疗治疗乳腺癌

2022-02-10

cathymary (审核中...)

前往app查看评论内容

#医药#

精鼎医药在WCG CenterWatch全球研究中心关系调研中被评为 "值得合作的CRO"

2022-01-20

cathymary (审核中...)

前往app查看评论内容

#医药#

NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权

2022-01-18

cathymary (审核中...)

前往app查看评论内容

#医药#

同源康医药完成3.3亿元C轮融资，厚纪资本领投，凯乘资本担任独家财务顾问

2022-01-09

cathymary (审核中...)

前往app查看评论内容

#医药#

阿南达医药科技宣布FDA批准了针对阿片类用药障碍（OUD）的新药临床试验申请

2022-01-07

cathymary (审核中...)

前往app查看评论内容

#医药#

四环医药（0460.HK）：轩竹生物完成超6亿元B轮融资，阳光人寿领投，凯乘资本担任独家财务顾问

2022-01-05

cathymary (审核中...)

前往app查看评论内容

#医药#

凌腾医药宣布，卡妥索双抗用于介苗治疗失败的非肌层浸润性膀胱癌的1期临床试验已完成首例患者给药

2021-12-12

cathymary (审核中...)

前往app查看评论内容

#医药#

丁香园生态合作伙伴大会在上海举行，聚焦医药数字化营销浪潮

2021-11-20

科室
- - 订阅+
  - 更多科室
工具
服务